LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $5,418,352

Key CONT_AWD_75N91018F00064_7529_HHSN261201500003I_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 81 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91018F00064_7529_HHSN261201500003I_7529
At the source https://www.usaspending.gov/award/CONT_AWD_75N91018F00064_7529_HHSN261201500003I_7529
Observed 2026-09-05, version 1, retrieved 2026-09-05T00:55:21Z
Content hash 65e23ee56142e5f32578a8ad2ab74fbd605b17ae36a8e7e44e363a31b726ba5b

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

VersionAmountChangeOccurredPublishedRetrievedHow it arrivedContent hash
1
current
$5,418,352first versionSeptember 17, 2018June 16, 20262026-09-05T00:55:21Zhistorical sweep65e23ee56142

Archived copy

https://web.archive.org/web/20261014114923/https://www.usaspending.gov/award/CONT_AWD_75N91018F00064_7529_HHSN261201500003I_7529 captured by this system, October 14, 2026

What the amount is made of

5 recorded actions, so the amount is the award's current total across all of them. 3 of them obligated money. Measured 2026-10-11, when USAspending reported a total obligation of $5,418,352.

Action dateModificationTypeObligatedDescription as recorded
June 16, 2026P00004OTHER ADMINISTRATIVE ACTIONno moneyANTIBODY PRODUCTION AND CHARACTERIZATION
April 7, 2023P00003OTHER ADMINISTRATIVE ACTIONno moneyANTIBODY PRODUCTION AND CHARACTERIZATION
September 29, 2019P00002EXERCISE AN OPTION+$2,164,546ANTIBODY PRODUCTION AND CHARACTERIZATION
August 14, 2019P00001EXERCISE AN OPTION+$2,176,347ANTIBODY PRODUCTION AND CHARACTERIZATION
September 17, 2018basenot on file+$1,077,459ANTIBODY PRODUCTION AND CHARACTERIZATION

Last refreshed November 4, 2026 at 2:31 PM UTC.